Efficacy of Tamarindus Indica Fruit Juice in Optimizing Cardiometabolic Health of Patients Living With HIV
Cardiometabolic Syndrome, Dyslipidemias, Hypertension
About this trial
This is an interventional treatment trial for Cardiometabolic Syndrome focused on measuring Vascular function, Tamarindus indica, Lipid metabolism, Glucose metabolism, Polyphenols, HIV
Eligibility Criteria
Inclusion Criteria: Triglycerides ≥150 mg/dL TLD regimen (ART) for ≥12 months 95% ART adherence in last 6 months Virally suppressed (most recent results viral load suppressed within the last 12 months) PLWH aged ≥30≤60 years. No plans to change location in the next 6 months Exclusion Criteria: Taking dietary supplements TB co-infection, renal failure disease, liver cirrhosis, chronic pancreatitis Pregnancy and Lactation or regular sport activity Parallel participation in another clinical trial On treatment for; dyslipidemia, hypertension or diabetes and oral hypoglycemic drugs Very low blood pressure (< 90/50 mmHg) Not willing to consent or unable to consent
Sites / Locations
- Kajjansi HCIVRecruiting
Arms of the Study
Arm 1
Arm 2
Active Comparator
Experimental
10% Tamarindus indica fruit pulp juice
30% Tamarindus indica fruit pulp juice
Participants will follow a daily consumption of 600ml of Tamarindus indica fruit juice containing 10% Tamarindus indica fruit pulp for 30 days
Participants will follow a daily consumption of 600ml of Tamarindus indica fruit juice containing 30% Tamarindus indica fruit pulp for 30 days